期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

二甲双胍对新诊断肥胖型2型糖尿病患者超敏C反应蛋白的影响 被引量：3

下载PDF
导出
摘要 新诊断肥胖T2DM74例随机分为治疗组(A组)38例和对照组(B组)36例,A组用甘精胰岛素加二甲双胍,共6月。对照组予甘精胰岛素加安慰剂。均查空腹血糖(FPG),餐后2小时血糖(PPG),糖化红蛋白(HbA1c),总胆固醇(TC)、甘油三脂(TG);低密度脂蛋白(LDL-C)(,h-CRP),肝肾功能。结果两组治疗前后h-CRP水平均显著下降(P<0.05),A组低于B组(P<0.05)。结论二甲双胍能降低新诊断肥胖型T2DM患者h-(CRP)的水平。
作者 万金星
机构地区 浙江省衢州市人民医院内分泌科
出处 《实用糖尿病杂志》 2010年第6期13-14,共2页 Journal of Practical Diabetology
关键词 2型糖尿病(T2DM) 二甲双胍 超敏C反应蛋白(h-CRP)
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献4

  • 1UK Prospective Diabetes Study (UKPDS) Group Effect of in- tense blood glucose control with metform in complications in over- weight patients with type 2 diabetes. Lancet 1998 ; 352 ( 1 ) : 854 - 855.
  • 2Wellen KE, Hotamisigil GS. Inflammaiton stressand diabetes. Clininvest 2005;115(5):1111-1119.
  • 3Wisse BE. The inflammation syndrome:the role of adipose tis- sue cytokines in metabolic disoeders linked to obesity. Am Soe Nephrol 2004;15(11) :2792 -2800.
  • 4Isodad DJ, Yang JL, Zirlid H, et al. Metform in inbibits proin- flammatory responses and nuclear factor - kB in human vascular wall ceils. Artericoscler Thromb Vasc Bio 2006;26(5) :611 -617.

同被引文献27

  • 1Ridker PM,Rifai N,Clearfield M,et al.Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events[J].N Engl J Med,2001,344(26):1959-1965.
  • 2Ridker PM,Rifai N,Pfeffer MA,et al.Inflammation,pravastatin,and the risk of coronary events after myocardial infarction in patients with average cholesterol levels.Cholesterol and Recurrent Events(CARE)Investigators[J].Circulation,1998,98(9):839-844.
  • 3Ridker PM,Morrow DA,Rose LM,et al.Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol<70 mg/dl and C-reactive protein<2 mg/l:an ananalysis of the PROVE-IT TIMI-22 trial[J].J Am Coll Cardiol,2005,45(10):1644-1648.
  • 4Ridker PM,Rifai N,Pfeffer MA,et al.Long-term effects of pravastatin on plasma concentration of C-reactive protein.The Cholesterol and Recurrent Events(CARE)Investigators[J].Circulation,1999,100(3):230-235.
  • 5Ismail-Beigi F,Craven T,Banerji MA,et al.Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2diabetes:an analysis of the ACCORD randomised trial[J].Lancet,2010,376(9739):419-430.
  • 6Ridker PM,Rifai N,Rose L,et al.Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J].N Engl J Med,2002,347(20):1557-1565.
  • 7Ukinc K,Ersoz HO,Erem C,et al.Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients[J].Endocrine,2009,35(3):380-388.
  • 8Parson HK,Bundy MA,Dublin CB,et al.Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes[J].Diabetes Metab Syndr Obes,2010,3:19-26.
  • 9Parson HK,Bundy MA,Dublin CB,et al.Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes.Diabetes Metab Syndr Obes,2010,3:19-26.
  • 10中国2型糖尿病防治指南（2007年版）[J].中华医学杂志,2008,88(18):1227-1245. 被引量：954

引证文献3

二级引证文献24

实用糖尿病杂志
2010年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部